Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.5980
-0.0410 (-6.42%)
At close: May 28, 2025, 4:00 PM
0.5821
-0.0159 (-2.66%)
After-hours: May 28, 2025, 5:55 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $9.94 million as of May 28, 2025.
Market Cap
9.94M
Enterprise Value
7.15M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $9.94M, a decrease of -70.23%. That is a compound annual growth rate of -82.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 10.77M | -44.86% |
| Dec 31, 2024 | 19.53M | -41.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 311.77B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |